Yin D - Search Results

1

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

Huang Y, Lin L, Shen Z, Li Y, Cao H, Peng L, Qiu Y, Cheng X, Meng M, Lu D, Yin D. Huang Y, et al. Among authors: yin d. Am J Cancer Res. 2020 Oct 1;10(10):3328-3344. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163273 Free PMC article.

2

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.

Yin D, Chen W, O'Kelly J, Lu D, Ham M, Doan NB, Xie D, Wang C, Vadgama J, Said JW, Black KL, Koeffler HP. Yin D, et al. Int J Cancer. 2010 Nov 15;127(10):2257-67. doi: 10.1002/ijc.25257. Int J Cancer. 2010. PMID: 20162579 Free PMC article.

3

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).

Lin L, Gaut D, Hu K, Yan H, Yin D, Koeffler HP. Lin L, et al. Among authors: yin d. Int J Oncol. 2014 Feb;44(2):557-62. doi: 10.3892/ijo.2013.2205. Epub 2013 Dec 2. Int J Oncol. 2014. PMID: 24297065 Free PMC article.

4

Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.

Zhang H, Li W, Huang P, Lin L, Ye H, Lin D, Koeffler HP, Wang J, Yin D. Zhang H, et al. Among authors: yin d. Oncol Rep. 2015 Mar;33(3):1481-92. doi: 10.3892/or.2015.3709. Epub 2015 Jan 8. Oncol Rep. 2015. PMID: 25571929

5

Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

Lin DC, Xu L, Chen Y, Yan H, Hazawa M, Doan N, Said JW, Ding LW, Liu LZ, Yang H, Yu S, Kahn M, Yin D, Koeffler HP. Lin DC, et al. Among authors: yin d. Cancer Res. 2015 May 1;75(9):1815-27. doi: 10.1158/0008-5472.CAN-14-1433. Epub 2015 Apr 15. Cancer Res. 2015. PMID: 25877876 Free PMC article.

6

Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence.

Huang P, Zhuang B, Zhang H, Yan H, Xiao Z, Li W, Zhang J, Tang Q, Hu K, Koeffler HP, Wang J, Yin D. Huang P, et al. Among authors: yin d. Clin Cancer Res. 2015 Oct 1;21(19):4420-30. doi: 10.1158/1078-0432.CCR-14-2067. Epub 2015 Jun 9. Clin Cancer Res. 2015. PMID: 26059188

7

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.

Yan H, Hu K, Wu W, Li Y, Tian H, Chu Z, Koeffler HP, Yin D. Yan H, et al. Among authors: yin d. PLoS One. 2016 Aug 17;11(8):e0159954. doi: 10.1371/journal.pone.0159954. eCollection 2016. PLoS One. 2016. PMID: 27532268 Free PMC article.

8

Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.

Lin DC, Mayakonda A, Dinh HQ, Huang P, Lin L, Liu X, Ding LW, Wang J, Berman BP, Song EW, Yin D, Koeffler HP. Lin DC, et al. Among authors: yin d. Cancer Res. 2017 May 1;77(9):2255-2265. doi: 10.1158/0008-5472.CAN-16-2822. Epub 2017 Feb 20. Cancer Res. 2017. PMID: 28302680 Free PMC article.

9

FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation.

Li Y, Hu K, Xiao X, Wu W, Yan H, Chen H, Chen Z, Yin D. Li Y, et al. Among authors: yin d. Biochem Biophys Res Commun. 2018 Mar 4;497(2):473-479. doi: 10.1016/j.bbrc.2018.01.192. Epub 2018 Feb 2. Biochem Biophys Res Commun. 2018. PMID: 29408378

10

ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer.

Guo X, Zhang Y, Mayakonda A, Madan V, Ding LW, Lin LH, Zia S, Gery S, Tyner JW, Zhou W, Yin D, Lin DC, Koeffler HP. Guo X, et al. Among authors: yin d. Oncogene. 2018 Nov;37(45):5939-5951. doi: 10.1038/s41388-018-0371-4. Epub 2018 Jul 6. Oncogene. 2018. PMID: 29980791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,743 results

Search Page

Filters